研究论文
Capecitabine-Based Chemoendocrine Combination as First-Line Treatment for Metastatic Hormone-Positive Metastatic Breast Cancer: Phase 2 Study
Noha Rashad, Thoraya Abdelhamid, Samia A. Shouman, Hanan Nassar, Mervat M. Omran, Eman D. El Desouky, Hussein Khaled
Armed Forces College of Medicine Cairo University
来源Clinical Breast Cancer
年份2020
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
420
20
23
424
25
26
关键指标
17
被引次数 · OpenAlex
0.38
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 41%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
41
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
当前基于文献信息回答
可就本文提问；依据不足时会说明。
学术脉络
学科主题
生物医学Cancer Treatment and Pharmacology
Breast Cancer Treatment Studies · Advanced Breast Cancer Therapies
参考文献 41
Evaluation of Tamoxifen and Metabolites by LC-MS/MS and HPLC Methods
被引 29Dennis D. Heath, Shirley W. Flatt, Alan H.B. Wu · British Journal of Biomedical Science · 2014
Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group.
被引 94Kathleen I. Pritchard, Alexander Paterson, Shai Fine · Journal of Clinical Oncology · 1997
Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial.
被引 214Bernard Fisher, Carol Redmond, A Brown · Journal of Clinical Oncology · 1986
此处列出前 3 条
引用本文 17
Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer—A Retrospective Analysis of Consecutive Patients Data
被引 13Anna Buda-Nowak, Łukasz Kwinta, Paweł Potocki · Journal of Clinical Medicine · 2023
Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: The Phase III MECCA Trial
被引 12Ruoxi Hong, Fei Xu, Wen Xia · Journal of Clinical Oncology · 2025
Metronomic chemotherapy combined with endocrine therapy: are we challenging some dogmas?
被引 10Rafael Caparica, Claudia De Angelis, Â. Fêde · Expert Review of Anticancer Therapy · 2020
按被引量排序，此处列出前 3 条